Application invited for the following post to the ICMR sanctioned clinical trial titled A phase III, multi center, randomized, double blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of single dose of dengue tetravalent vaccine, live attenuated Recombinant, Lyophilized DengiAll to Dr. Anil S Bilimale, Chief MPH Coordinator, School of Public Health, JSS AHER for the remaining period of twenty months
07-03-2026 to 14-03-2026